ConsortiEX Blog

FDA Issues New Guidance on Suspect and Illegitimate Product

The FDA recently issued guidance on the definition of Suspect and Illegitimate Products, set forth in the Federal Food Drug and Cosmetic Act1. This guidance aims to assist trading partners in putting systems in place to identify and handle suspect and illegitimate products, meeting Drug Supply Chain Security Act[...]

FDA Releases Final Guidance on Upcoming Product Identifier Requirements

On Sep. 9, 2018, the FDA released a Final Guidance regarding the use of product identifiers on packages and homogenous cases of product as mentioned in the Drug Supply Chain Security Act (DSCSA).

1

Topics

See all